Genome-wide analyses identify KIF5A as a novel ALS gene A Nicolas, KP Kenna, AE Renton, N Ticozzi, F Faghri, R Chia, ... Neuron 97 (6), 1267-1288, 2018 | 596 | 2018 |
ALS phenotype is influenced by age, sex, and genetics: a population-based study A Chiò, C Moglia, A Canosa, U Manera, F D'Ovidio, R Vasta, M Grassano, ... Neurology 94 (8), e802-e810, 2020 | 134 | 2020 |
Early weight loss in amyotrophic lateral sclerosis: outcome relevance and clinical correlates in a population-based cohort C Moglia, A Calvo, M Grassano, A Canosa, U Manera, F D'Ovidio, ... Journal of Neurology, Neurosurgery & Psychiatry 90 (6), 666-673, 2019 | 101 | 2019 |
A prospective longitudinal study on the microbiota composition in amyotrophic lateral sclerosis D Di Gioia, N Bozzi Cionci, L Baffoni, A Amoruso, M Pane, L Mogna, ... BMC medicine 18, 1-19, 2020 | 93 | 2020 |
Potential role of gut microbiota in ALS pathogenesis and possible novel therapeutic strategies L Mazzini, L Mogna, F De Marchi, A Amoruso, M Pane, I Aloisio, ... Journal of clinical gastroenterology 52, S68-S70, 2018 | 86 | 2018 |
Immunity in amyotrophic lateral sclerosis: Blurred lines between excessive inflammation and inefficient immune responses LC Béland, A Markovinovic, H Jakovac, F De Marchi, E Bilic, L Mazzini, ... Brain communications 2 (2), fcaa124, 2020 | 85 | 2020 |
Results from phase I clinical trial with intraspinal injection of neural stem cells in amyotrophic lateral sclerosis: a long-term outcome L Mazzini, M Gelati, DC Profico, G Sorarù, D Ferrari, M Copetti, G Muzi, ... Stem cells translational medicine 8 (9), 887-897, 2019 | 78 | 2019 |
A case of acute demyelinating polyradiculoneuropathy with bilateral facial palsy after ChAdOx1 nCoV-19 vaccine NA Nasuelli, F De Marchi, M Cecchin, I De Paoli, S Onorato, R Pettinaroli, ... Neurological Sciences 42, 4747-4749, 2021 | 60 | 2021 |
Telehealth in neurodegenerative diseases: opportunities and challenges for patients and physicians F De Marchi, E Contaldi, L Magistrelli, R Cantello, C Comi, L Mazzini Brain sciences 11 (2), 237, 2021 | 52 | 2021 |
Decline of cognitive and behavioral functions in amyotrophic lateral sclerosis: a longitudinal study E Bersano, MF Sarnelli, V Solara, B Iazzolino, L Peotta, F De Marchi, ... Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 21 (5-6), 373-379, 2020 | 51 | 2020 |
Pharmacotherapy for amyotrophic lateral sclerosis: a review of approved and upcoming agents SA Johnson, T Fang, F De Marchi, D Neel, D Van Weehaeghe, JD Berry, ... Drugs 82 (13), 1367-1388, 2022 | 47 | 2022 |
Depression and risk of cognitive dysfunctions in amyotrophic lateral sclerosis F De Marchi, MF Sarnelli, V Solara, E Bersano, R Cantello, L Mazzini Acta Neurologica Scandinavica 139 (5), 438-445, 2019 | 43 | 2019 |
Advances in stem cell therapy for amyotrophic lateral sclerosis L Mazzini, D Ferrari, PR Andjus, L Buzanska, R Cantello, F De Marchi, ... Expert opinion on biological therapy 18 (8), 865-881, 2018 | 41 | 2018 |
Integration of a palliative care specialist in an amyotrophic lateral sclerosis clinic: observations from one center K Brizzi, S Paganoni, A Zehm, F De Marchi, JD Berry Muscle & Nerve 60 (2), 137-140, 2019 | 34 | 2019 |
Critical illness neuro-myopathy (CINM) and focal amyotrophy in intensive care unit (ICU) patients with SARS-CoV-2: a case series NA Nasuelli, R Pettinaroli, L Godi, C Savoini, F De Marchi, L Mazzini, ... Neurological Sciences 42 (3), 1119-1121, 2021 | 33 | 2021 |
A pilot trial of RNS60 in amyotrophic lateral sclerosis S Paganoni, MJ Alshikho, S Luppino, J Chan, L Pothier, D Schoenfeld, ... Muscle & nerve 59 (3), 303-308, 2019 | 33 | 2019 |
Interplay between immunity and amyotrophic lateral sclerosis: Clinical impact F De Marchi, I Munitic, A Amedei, JD Berry, EL Feldman, E Aronica, ... Neuroscience & Biobehavioral Reviews 127, 958-978, 2021 | 32 | 2021 |
Telehealth approach for amyotrophic lateral sclerosis patients: the experience during COVID‐19 pandemic F De Marchi, MF Sarnelli, M Serioli, I De Marchi, E Zani, N Bottone, ... Acta Neurologica Scandinavica 143 (5), 489-496, 2021 | 31 | 2021 |
Telemedicine and technological devices for amyotrophic lateral sclerosis in the era of COVID-19 F De Marchi, R Cantello, S Ambrosini, L Mazzini, ... Neurological Sciences 41 (6), 1365-1367, 2020 | 29 | 2020 |
Identifying and predicting amyotrophic lateral sclerosis clinical subgroups: a population-based machine-learning study F Faghri, F Brunn, A Dadu, A Chiò, A Calvo, C Moglia, A Canosa, ... The Lancet Digital Health 4 (5), e359-e369, 2022 | 28 | 2022 |